ABOS Acumen Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABOS

Price (delayed)

$3.135

Market cap

$188.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$152.28M

Highlights
Acumen Pharmaceuticals's EPS has increased by 3.6% from the previous quarter
The company's equity rose by 41% YoY but it fell by 4.7% QoQ
The company's quick ratio fell by 47% QoQ and by 17% YoY
Acumen Pharmaceuticals's net income has decreased by 22% YoY and by 7% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of ABOS
Market
Shares outstanding
60.08M
Market cap
$188.35M
Enterprise value
$152.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.68
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$51.79M
EBITDA
-$51.61M
Free cash flow
-$43.08M
Per share
EPS
-$1.08
Free cash flow per share
-$0.89
Book value per share
$4.61
Revenue per share
$0
TBVPS
$6.38
Balance sheet
Total assets
$310.13M
Total liabilities
$43.15M
Debt
$31.05M
Equity
$266.97M
Working capital
$233.64M
Liquidity
Debt to equity
0.12
Current ratio
19.01
Quick ratio
18.79
Net debt/EBITDA
0.7
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-21.8%
Return on equity
-23.4%
Return on invested capital
-32.4%
Return on capital employed
-17.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABOS stock price

How has the Acumen Pharmaceuticals stock price performed over time
Intraday
-1.42%
1 week
-0.79%
1 month
-26.24%
1 year
-14.34%
YTD
-18.36%
QTD
-22.59%

Financial performance

How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$61.14M
Net income
-$52.37M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's operating income has decreased by 35% YoY and by 7% QoQ
Acumen Pharmaceuticals's net income has decreased by 22% YoY and by 7% from the previous quarter

Growth

What is Acumen Pharmaceuticals's growth rate over time

Valuation

What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.68
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has increased by 3.6% from the previous quarter
The company's equity rose by 41% YoY but it fell by 4.7% QoQ
The P/B is 23% less than the last 4 quarters average of 0.9

Efficiency

How efficient is Acumen Pharmaceuticals business performance
ABOS's ROIC is up by 43% YoY and by 27% from the previous quarter
ABOS's return on equity is down by 10% year-on-year but it is up by 2.1% since the previous quarter
ABOS's ROA is down by 6% year-on-year but it is up by 5% since the previous quarter

Dividends

What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABOS.

Financial health

How did Acumen Pharmaceuticals financials performed over time
Acumen Pharmaceuticals's total assets has soared by 58% YoY and by 8% from the previous quarter
The company's quick ratio fell by 47% QoQ and by 17% YoY
The company's debt is 88% lower than its equity
The company's equity rose by 41% YoY but it fell by 4.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.